21 May 2013
Keywords: genentech, sets, up, new, hiv, vaccine, company
Article | 26 February 1996
Genentech of the USA has created a new firm, Genenvax, to expand
development of gp120, Genen-tech's potential vaccine for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 1996
4 March 1996
20 May 2013
© 2013 thepharmaletter.com